|
|
Q4 2020
Filed on Jan 29, 2021
|
60
|
$3.28 - $6.21
$197 - $373
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
988
|
$27.29 - $34.46
$27K - $34K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
125
|
$25.31 - $31.0
$3.16K - $3.88K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
18
|
$3.95 - $5.42
$71.1 - $97.6
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
300
|
$60.76 - $93.91
$18.2K - $28.2K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
39
|
$9.03 - $19.2
$352 - $749
|
|
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
470
|
$26.08 - $27.54
$12.3K - $12.9K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
64
|
$52.26 - $67.84
$3.34K - $4.34K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
1,628
|
$9.83 - $11.15
$16K - $18.2K
|
|
Danaher Corp Del 0 01/22/2021
|
Q4 2020
Filed on Jan 29, 2021
|
1,000
|
N/A
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
9
|
$1.89 - $13.42
$17 - $121
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
52
|
$13.16 - $18.25
$684 - $949
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
10
|
$66.34 - $80.32
$663 - $803
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
194
|
$27.29 - $31.62
$5.29K - $6.13K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
13
|
$1.99 - $3.35
$25.9 - $43.6
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
325
|
N/A
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
40
|
$13.36 - $30.65
$534 - $1.23K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
259
|
$128.09 - $159.06
$33.2K - $41.2K
|
|
|
|
Teva Pharmaceutical Fin LLC 0.25 02/01/2026
|
Q4 2020
Filed on Jan 29, 2021
|
5,000
|
N/A
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
835
|
$33.63 - $46.58
$28.1K - $38.9K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
47
|
$32.44 - $40.19
$1.52K - $1.89K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
981
|
$24.84 - $40.0
$24.4K - $39.2K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
158
|
$216.72 - $246.38
$34.2K - $38.9K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
1,680
|
$23.71 - $28.18
$39.8K - $47.3K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
16
|
$3.97 - $7.64
$63.5 - $122
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
122
|
$21.55 - $40.48
$2.63K - $4.94K
|
|
Novellus Sys Inc 2.625 05/15/2041
|
Q4 2020
Filed on Jan 29, 2021
|
2,000
|
N/A
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
50
|
$10.52 - $19.68
$526 - $984
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
6
|
$35.96 - $55.39
$216 - $332
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
200
|
$1.55 - $2.05
$310 - $410
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
5,000
|
$24.66 - $25.05
$123K - $125K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
391
|
$15.9 - $31.45
$6.22K - $12.3K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
100
|
N/A
|
|
Mallinckrodt Pub LTD CO Shs
|
Q4 2020
Filed on Jan 29, 2021
|
31
|
N/A
|
|
Biomarin Pharmaceutical Inc 1.5 10/15/2020
|
Q4 2020
Filed on Jan 29, 2021
|
3,000
|
N/A
|
|
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
340
|
$51.24 - $57.75
$17.4K - $19.6K
|
|
Vereit Inc 3.75 12/15/2020
|
Q4 2020
Filed on Jan 29, 2021
|
3,000
|
N/A
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
18
|
$6.82 - $10.0
$123 - $180
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
30
|
$106.92 - $118.66
$3.21K - $3.56K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
16
|
$25.91 - $30.19
$415 - $483
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
5
|
$7.48 - $19.47
$37.4 - $97.4
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
5
|
$64.9 - $86.15
$325 - $431
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
935
|
$8.23 - $10.88
$7.7K - $10.2K
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
16
|
$9.15 - $16.97
$146 - $272
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
5
|
$4.56 - $8.86
$22.8 - $44.3
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
1
|
$13.01 - $21.17
$13 - $21.2
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
8
|
$42.35 - $52.0
$339 - $416
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
4
|
$14.03 - $29.66
$56.1 - $119
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
7
|
$9.15 - $18.65
$64.1 - $131
|
|
|
|
Q4 2020
Filed on Jan 29, 2021
|
9
|
$678.4 - $835.0
$6.11K - $7.52K
|
|